United States S 102: Prescription Drug Price Relief Act of 2019

Status: Introduced in Senate (as of 2019-01-10)

State: United States · Session: 116 · Bill: S 102

Subjects: Administrative remedies, Asia, Business records, Canada, Civil actions and liability, Competition and antitrust, Department of Health and Human Services, Drug safety, medical device, and laboratory regulation, Europe, France, Germany, Government information and archives, Government studies and investigations, Health care costs and insurance, Health information and medical records, Inflation and prices, Intellectual property, Japan, Licensing and registrations, Manufacturing, Marketing and advertising, Medical research, Prescription drugs, Research and development, United Kingdom

Sponsors: Bernard Sanders, Amy Klobuchar, Cory A. Booker, Elizabeth A. Warren, Kamala D. Harris, Kirsten E. Gillibrand, Richard Blumenthal

View United States S 102 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.